Clinical Trials
Pfizer unveils new Phase 2 data on 20-valent pneumococcal...
Pfizer has revealed new Phase 2 data on its 20-valent pneumococcal conjugate vaccine candidate, known as PF-06482077 (20vPnC) Detailing the efficacy of...
Clinical Trials
Biokin Pharmaceutical Selects Cryoport’s Temperature-Controlled Solutions for its Pending...
Biokin Pharmaceutical Co. Ltd. a leading pharmaceutical company with operations in China and U.S., and Cryoport, Inc. , the world's leading temperature-controlled logistics company dedicated...
Articles
2019 Trends to Watch For in the Global Clinical...
The industry’s pledge to improve the clinical trial experience for participants and investigative sites is taking center stage in 2019. Greenphire’s CEO, Jim Murphy, spoke...
Clinical Trials
Clinerion partners with MEDSOFT on expanding clinical research in...
Clinerion will offer its services to hospitals in Georgia, bringing them access to international clinical studies and the use of Patient Network Explorer for academic...
Clinical Trials
Ochsner Health System and Pfizer Partner to Develop Innovative...
Ochsner Health System, Louisiana’s largest non-profit academic healthcare system, and Pfizer Inc have entered into a multi-year strategic alliance to develop innovative models for clinical...
Clinical Trials
CStone receives CTA approval in China to start Phase...
CStone Pharmaceuticals announced that the National Medical Products Administration (NMPA) recently approved the clinical trial application (CTA) to start a Phase I clinical trial in...
Clinical Trials
Bavarian Nordic Completes Enrollment of First Stage in Chordoma...
Bavarian Nordic A/S announced , that the first stage of a Phase 2 study of its novel, targeted cancer immunotherapy candidate, BN-Brachyury in the treatment...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.